Trials / Completed
CompletedNCT06991894
Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study
Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Retrospective Medical Claims Database Study (Eltrombopag for Aplastic Anemia)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,517 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 15 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of this study was to investigate the effectiveness and safety of eltrombopag (ETB) when compared to other treatments in Japanese aplastic anemia (AA) patients using data from the Medical Data Vision (MDV) hospital-based database.
Conditions
Timeline
- Start date
- 2021-07-14
- Primary completion
- 2024-05-17
- Completion
- 2024-05-17
- First posted
- 2025-05-28
- Last updated
- 2025-05-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06991894. Inclusion in this directory is not an endorsement.